Volume 30, Issue 2 (Avicenna Journal of Clinical Medicine-Summer 2023)
Avicenna J Clin Med 2023, 30(2): 99-105 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sobhan M R, Jamshidi M, Ghasemibasir H R, Khanlarzadeh E. Evaluation of Serum Leptin Level in Psoriasis Patients and its Relation with the Severity of Disease. Avicenna J Clin Med 2023; 30 (2) :99-105
URL: http://sjh.umsha.ac.ir/article-1-2721-en.html
URL: http://sjh.umsha.ac.ir/article-1-2721-en.html
Evaluation of Serum Leptin Level in Psoriasis Patients and its Relation with the Severity of Disease
1- Department of Dermatology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2- Department of Dermatology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , jamshidim84@yahoo.com
3- Department of Pathology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
4- Department of Social Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2- Department of Dermatology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , jamshidim84@yahoo.com
3- Department of Pathology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
4- Department of Social Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract: (249 Views)
Background and Objective: The association of leptin with psoriasis is currently controversial. The purpose of this study was to evaluate serum leptin levels in patients with psoriasis and its relationship with the severity of the disease.
Materials and Methods: In this case-control study, serum leptin levels were measured in 40 patients with psoriasis and 40 age- and gender-matched healthy controls by sandwich enzyme-linked immunosorbent assay method. The severity of psoriasis was assessed by the Psoriasis Area and Severity Index (PASI). Data were analyzed using SPSS software version 16.
Results: Of 40 patients, 35 (87.5%) had plaque psoriasis, 3 (7.5%) had palmo-plantar, and one of the remaining two patients had erythrodermic psoriasis while the other one had a pustular type. The mean disease severity based on PASI was 10.2 with a range of 0.8 to 39.9. The most common sites of involvement were generalized (27.5%), upper and lower extremities together (20.0%), lower extremities alone (15%), and trunk and lower extremities (15%) in descending order. Leptin was higher in the patient group than the control group (19.2±16.3 ng/ml versus 15.5±16.1 ng/ml) (P=0.227). The correlation between leptin and body mass index was positive and significant in both groups. No significant relationship was found between the severity and duration of disease and leptin.
Conclusion: The findings of this study showed that similar to most studies, serum leptin levels were higher in patients with psoriasis than in healthy subjects, and in obese people, this difference was greater than in normal-weight individuals
Materials and Methods: In this case-control study, serum leptin levels were measured in 40 patients with psoriasis and 40 age- and gender-matched healthy controls by sandwich enzyme-linked immunosorbent assay method. The severity of psoriasis was assessed by the Psoriasis Area and Severity Index (PASI). Data were analyzed using SPSS software version 16.
Results: Of 40 patients, 35 (87.5%) had plaque psoriasis, 3 (7.5%) had palmo-plantar, and one of the remaining two patients had erythrodermic psoriasis while the other one had a pustular type. The mean disease severity based on PASI was 10.2 with a range of 0.8 to 39.9. The most common sites of involvement were generalized (27.5%), upper and lower extremities together (20.0%), lower extremities alone (15%), and trunk and lower extremities (15%) in descending order. Leptin was higher in the patient group than the control group (19.2±16.3 ng/ml versus 15.5±16.1 ng/ml) (P=0.227). The correlation between leptin and body mass index was positive and significant in both groups. No significant relationship was found between the severity and duration of disease and leptin.
Conclusion: The findings of this study showed that similar to most studies, serum leptin levels were higher in patients with psoriasis than in healthy subjects, and in obese people, this difference was greater than in normal-weight individuals
Type of Study: Original |
Subject:
Dermatology
Extended Abstract [HTML 25 KB] (15 Download)
References
1. Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014;13(4-5):490-5. PMID: 24434359 DOI: 10.1016/j.autrev.2014.01.008
2. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol. 2009;60:218-24. PMID: 19022533 DOI: 10.1016/j.jaad.2008.09.022
3. Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, Gómez-Reino JJ, et al. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett. 2005;579(2):295-301.
4. Oka A, Mabuchi T, Ozawa A, Inoko H. Current understanding of human genetics and genetic analysis of psoriasis. J Dermatol. 2012;39(3):231-41. PMID: 22352847 DOI: 10.1111/j.1346-8138.2012.01504.x
5. Baran A, Flisiak I, Jaroszewicz J, Świderska M. Effect of psoriasis activity on serum adiponectin and leptin levels. Postepy Dermatol Alergol. 2015;32(2):101-6. PMID: 26015779 DOI: 10.5114/pdia.2014.40960
6. Zhu KJ, Zhang C, Li M, Zhu CY, Shi G, Fan YM. Leptin levels in patients with psoriasis: a meta‐analysis. Clin Exp Dermatol. 2013;38(5):478-83. PMID: 23777488 DOI: 10.1111/ced.12171
7. Cerman AA, Bozkurt SÜ, Sav A, Tulunay A, Elbaşı MO, Ergun T. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol. 2008;159(4):820-6. PMID: 18637894 DOI: 10.1111/j.1365-2133.2008.08742.x
8. Oh YJ, Lim HK, Choi JH, Lee JW, Kim NI. Serum leptin and adiponectin levels in Korean patients with psoriasis. J Korean Med Sci. 2014;29(5):729-34. PMID: 24851032 DOI: 10.3346/jkms.2014.29.5.729
9. Tehranchinia Z, Niroomand M, Kazeminejad A, Ghahari MJ, Radvar S, Sadat-Amini H, et al. Leptin and sex hormones in psoriasis and correlation with disease severity. Iran J Dermatol. 2014;17:43-8.
10. Ghalaut VS, Sarkar M, Dayal S, Gupta G, Samanta S, Rajju T. Status of Serum Leptin and Lipid Profile in Newly Diagnosed Psoriasis Patients: A Case Control Study. J Eur Acad Dermatol Venereol. 2007;21(10):1330-2. PMID: 17958837 DOI: 10.1111/j.1468-3083.2007.02260.x
11. Agamia NF, Gomaa SH. Evaluation of soluble p-selectin and leptin serum levels in sera of patients of psoriasis and their possible role in the increase in the cardiovascular risks in psoriatic patients. J Clin Exp Dermatol Res. 2014;5:201.
12. Johnston A, Arnadottir S, Gudjonsson JE, Aphale A, Sigmarsdottir AA, Gunnarsson SI, et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol. 2008;159(2):342-50.
13. Chen YJ, Wu CY, Shen JL, Chu SY, Chen CK, Chang YT, et al. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermato. 2008;144(12):1571-5. PMID: 19075139 DOI: 10.1001/archderm.144.12.1571
14. Fleming P, Kraft J, Gulliver WP, Lynde C. The relationship of obesity with the severity of psoriasis: a systematic review. J Cutan Med Surg. 2015;19(5):450-6. PMID: 26271963 DOI: 10.1177/1203475415586332
15. Sultana A, Bhuiyan SI, Mahmud MM, Siddique RU, Shawkat SM, Nandi AK. Comorbidities in patients with psoriasis. Mymensingh Med J. 2019;28(4):894-9. PMID: 31599257
16. Patel P, Rosen CF, Chandran V, Ye YJ, Gladman DD. Addressing comorbidities in psoriatic disease. Rheumatol Int. 2018;38(2):219-27. PMID: 29185085 DOI: 10.1007/s00296-017-3895-y
17. Berne B, Blom I, Spångberg S. Enhanced response of psoriasis to UVB therapy after pretreatment with a lubricating base. A single-blind controlled study. Acta Derm Venereol. 1990;70(6):474-7. PMID: 1981418
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Hamadan University of Medical Sciences
Published by UMSHA Press
Journal Tel: +988138380924
Publisher Tel:+988138380548
Website: http://sjh.umsha.ac.ir
Email: s_ journal[at]umsha.ac.ir
